Onyx announces $8M seed round to build a “virtual immune system”

Onyx announced an $8 million seed round led by Dimension to build what it calls a virtual immune system. The company says its data platform links genomics, transcriptomics, proteomics and metabolomics with clinical histories to study how people respond to infection, inflammation and treatment over time. Onyx says nearly 1,000 people have joined its research studies.